98%
921
2 minutes
20
Objectives: Chronic rhinosinusitis (CRS) is a widely prevalent condition, however its degree of severity according to sex requires further study. The literature shows that sex-based differences exist in the severity of asthma and allergic airway disease in the population. These findings point to a potential hormonal cause for this difference, but there is no study suggesting the role of sex in CRS with nasal polyps (CRSwNP). The purpose of this study was to examine the association of sex and CRSwNP severity in the United States.
Methods: This study was conducted on data gathered from 181 participants in the NAVIGATE I and NAVIGATE II randomized control trials within the OPTINOSE database. Participants were analyzed based on sex controlling for airway-related comorbidities, including history of asthma, race, and ethnicity. SNOT-22 scores were assessed as a quality-of-life outcome measure for CRS. The association between sex and SNOT-22 scores was determined using multiple linear regression.
Results: There were 81 female and 100 male participants. SNOT-22 scores were significantly higher in females. The average reported SNOT-22 score was 53.8 ± 16.5 in females and 46.8 ± 18.8 in males. On adjusted regression, the association of sex and SNOT-22 scores approached but didn't reach significance (β: -4.97; 95 % CI: -10.68-0.73; p = 0.09).
Conclusions: On average, females had more severe manifestations of CRSwNP in comparison to males, with the adjusted association approaching statistical significance. Further studies, potentially looking at hormones as a cause of pathogenesis, are needed to better elucidate the role of sex in CRSwNP.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.amjoto.2024.104465 | DOI Listing |
Braz J Otorhinolaryngol
September 2025
Faculdade de Medicina de Ribeirão Preto - Universidade de São Paulo, São Paulo, SP, Brazil.
Introduction: Chronic rhinosinusitis with nasal polyp (CRSwNP) is a predominant type 2 inflammatory disease, affecting the sense of smell and quality of life. Loss of smell compromises physical and emotional health, creating negative impacts and its treatment in CRSwNP is challenging.
Aim: To present the outcomes of dupilumab in olfactory function, Nasal Polyp Score (NPS) and quality of life in Brazilian patients with severe CRSwNP.
J Allergy Clin Immunol
September 2025
Department of Otolaryngology, the Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China. Electronic address:
Background: Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is a heterogeneous disorder characterized by diverse inflammatory signatures and endotypes.
Objective: To develop a histology-based deep learning network for predicting inflammatory gene signatures and spatial patterns in CRSwNP.
Methods: We developed HE2Signature, a deep learning model, using 70 H&E-stained whole-slide images (WSIs) of nasal polyps paired with corresponding endotypic signature gene expression profiles derived from transcriptomic data.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
September 2025
To explore the effect, postoperative mucosal pathological changes and molecular biological changes of reboot operation for type 2 inflammation chronic rhinosinusitis with nasal polyps(CRSwNP) patients, and to provide theoretical basis for the clinical application of this kind of operation. We collected 29 patients who were diagnosed with CRSwNP with type 2 inflammatino response and underwent Reboot surgery from June 2022 to August 2023, and 27 patients who were diagnosed with deviated septum and underwent simple submucosal resection of the septum as the control group. We conducted nasal symptom scoring, endoscopic sinusitis scoring, and CT scanning of the sinuses before and after surgery, as well as HE staining, immunohistochemical staining, and detection of inflammatory factors using Elisa kits at the time of surgery, 1, 3, and 6 months postoperatively.
View Article and Find Full Text PDFLancet
August 2025
ENT Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Background: A paucity of evidence regarding use of endoscopic sinus surgery and antibiotics in managing chronic rhinosinusitis has contributed to a five-times variation in endoscopic sinus surgery rates, as well as variation in the use of antibiotics. The main aim of the present trial was to compare the clinical effectiveness of endoscopic sinus surgery or 3 months of clarithromycin treatment alongside intranasal medication in adults with chronic rhinosinusitis with or without nasal polyps.
Methods: In this pragmatic, three-arm, randomised, placebo-controlled phase 4 trial, participants were recruited from 20 secondary and tertiary care sites in the UK.
Respir Med
August 2025
Ankara University Faculty of Medicine, Department of Chest Diseases, Division of Immunology and Allergic Diseases, Ankara. Electronic address:
Background: Benralizumab, a monoclonal antibody targeting IL-5α receptors, is approved for the treatment of severe eosinophilic asthma (SEA). Despite proven efficacy in randomized controlled trials, real-life data remain limited. This study aimed to evaluate effectiveness of benralizumab in real-life settings.
View Article and Find Full Text PDF